Early Detection of MG May Lessen Symptom Severity - Medscape
Jul 12, 2024 · Early detection of myasthenia gravis, along with timely treatment, could mitigate symptom severity and optimize outcomes, reports Dr Nicholas Silvestri.
Myasthenia Gravis: What Role Does Heredity Play? - Medscape
Oct 18, 2024 · SAVANNAH, GEORGIA — One patient with autoimmune myasthenia gravis (MG) has a niece with the same diagnosis, and at least one of his other close relatives may have it …
Myasthenia Gravis: Advice for the Generalist - Medscape
Apr 3, 2024 · Neurologists Kathrin LaFaver and Kim Robeson-Gewuerz discuss what tests and treatments you should consider when myasthenia gravis is suspected.
Myasthenia Gravis Treatment: 5 Things to Know - Medscape
Jun 28, 2024 · Myasthenia gravis, a rare autoimmune disease, can have devastating consequences. Stay current on the latest and emerging MG treatments with these five things …
Highlights in Myasthenia Gravis From AAN 2025 - Medscape
Apr 30, 2025 · Highlights in myasthenia gravis from AAN 2025 include trials of new therapy inebilizumab, new data on the approved rozanolixizumab for ocular symptoms, and insights …
Myasthenia Gravis: Exercise and Lifestyle Considerations
Sep 21, 2023 · Drs Nicholas Silvestri and Kelly Gwathmey discuss how exercise and other modifiable lifestyle factors can influence how patients experience the burden of myasthenia …
Promising Results for Investigational Myasthenia Gravis Drug
Mar 13, 2024 · Treatment with the investigational monoclonal antibody drug batoclimab significantly improved symptoms in patients with antibody-positive generalized myasthenia …
New Steroid Dosing Regimen for Myasthenia Gravis - Medscape
Feb 16, 2021 · Myasthenia gravis is a disorder of neuromuscular transmission, resulting from autoantibodies to components of the neuromuscular junction, most commonly the …
Zilucoplan May Decrease Symptoms of Myasthenia Gravis
May 15, 2019 · The novel self-administered subcutaneous agent is safe and relatively well tolerated in generalized myasthenia gravis, a new phase 2 trial and extension study report.
Key Updates in Myasthenia Gravis From AANEM 2025 - Medscape
Myasthenia gravis updates from AANEM 2025 include efficacy data for efgartigimod, telitacicept, and gefurulimab, plus interim results for a CAR T-cell therapy and DNTH10, an active C1S …